Sharp, a unit of UDG Healthcare PLC, initiated an Injectables Center of Excellence in 2016 at its Allentown, PA, campus; then expanded its prefilled-syringe and cold storage capacity. Now, together with a client co-investment, it is installing additional capabilities there as well as at its Conshohocken facility.
“We are seeing increased demand for our packaging capabilities from clients across the biotech industry, with the injectables sector growing significantly in recent years,” said Kevin Orfan, US president of Sharp Packaging. “This expansion is intended to support that demand into the future.”
Additions include vial labellers as well as a Vaporized Hydrogen Peroxide (HPV) cold sterilization system. Across the company, recent investments include $11 million on its new Clinical Services Centre of Excellence in Wales, England, an additional $11 million on enhancing its injectable and cold chain capabilities in the US, Belgium and the Netherlands, and $23 million on its recently refitted state-of-the-art facility in Bethlehem, PA.